{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:22:27Z","timestamp":1787656947359,"version":"build-2736575974"},"reference-count":49,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Backgrounds and Objectives: Using certain medications during an intercurrent illness can increase the risk of drug related problems (DRP) occurring such as acute kidney injury (AKI). Medications that increase this risk include sulfonylureas, angiotensin converting enzyme inhibitors, diuretics, metformin, angiotensin receptor blockers, non-steroidal anti-inflammatories drugs, and sodium glucose co-transporter 2 inhibitors (SADMANS). Sick day medication guidance (SDMG) recommends withholding SADMANS medications during an intercurrent illness where adequate fluid intake cannot be maintained. But uptake of these recommendations is poor, and it is not known whether Australian pharmacists currently provide these recommendations during home medicine reviews (HMR) as per SDMG. We aimed to gain an understanding of the characteristics of DRP identified by pharmacists during HMR, especially those relating to SADMANS medications. Materials and Methods: We conducted a retrospective audit of 201 randomly selected HMR reports, conducted by accredited pharmacists from 2020 to 2022, that were analysed in 2023. All DRP and recommendations were categorised using a modified DOCUMENT system. Results: Overall, over 98% of participants experienced a DRP and a total of 710 DRP were found, where participants experienced an average of 4.0 \u00b1 2.0 DRP each. Non-SADMANS medications accounted for 83.1% of all DRPs, with nervous system medications contributing the most. Common problems seen in non-SADMANS medications were related to toxicity, over\/underdosing and undertreating. Diuretics contributed most to DRP in SADMANS medications. Problems with SADMANS were mainly related to toxicity and contraindications. No pharmacists provided SDMG despite 71.1% of participants using at least one SADMANS medication. Conclusions: We conclude that DRP remain prevalent in community pharmacy settings. Sick day recommendations were not provided in the HMRs included in our study, possibly due to lack of pharmacist knowledge and awareness. To ensure best practice, more research should be conducted to determine pharmacists\u2019 knowledge of and barriers to provision of sick day recommendations.<\/jats:p>","DOI":"10.3390\/medicina60050798","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T10:26:36Z","timestamp":1715682396000},"page":"798","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug-Related Problems and Recommendations Made during Home Medicines Reviews for Sick Day Medication Management in Australia"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1018-3931","authenticated-orcid":false,"given":"Mimi","family":"Truong","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Van","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-007X","authenticated-orcid":false,"given":"Kamal","family":"Sud","sequence":"additional","affiliation":[{"name":"Nepean Kidney Research Centre, Department of Renal Medicine, Nepean Hospital, Nepean and Blue Mountains Local Health District, Kingswood 2747, Australia"},{"name":"Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubshet","family":"Tesfaye","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Health and Behavioural Sciences, The University of Queensland, Brisbane 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerida","family":"Croker","sequence":"additional","affiliation":[{"name":"Meditrax, Drummoyne 2047, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey","family":"Seth","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Lynel","family":"Castelino","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"},{"name":"Pharmacy Department, Blacktown Hospital, Western Sydney Local Health District, Blacktown 2148, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40264-021-01144-1","article-title":"The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021","volume":"45","author":"Lim","year":"2022","journal-title":"Drug Saf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsps.2013.05.006","article-title":"Systemic review on drug related hospital admissions\u2014A pubmed based search","volume":"23","author":"Nivya","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"ref_3","first-page":"192","article-title":"Drug-related morbidity and mortality: Updating the cost-of-illness model","volume":"41","author":"Ernst","year":"2001","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s41999-018-0124-5","article-title":"Association of polypharmacy and hyperpolypharmacy with frailty states: A systematic review and meta-analysis","volume":"10","author":"Palmer","year":"2019","journal-title":"Eur. Geriatr. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40266-022-00983-6","article-title":"Risk factors predictive of adverse drug events and drug-related falls in aged care residents: Secondary analysis from the ReMInDAR trial","volume":"40","author":"Dorj","year":"2023","journal-title":"Drugs Aging"},{"key":"ref_6","first-page":"173","article-title":"Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies","volume":"24","author":"Lord","year":"2018","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.jcjd.2017.11.004","article-title":"Chronic Kidney Disease in Diabetes","volume":"42","author":"McFarlane","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/picr.PICR_110_18","article-title":"Evaluation of prescribing practices and drug-related problems in chronic kidney disease patients: A cross-sectional study","volume":"11","author":"Subeesh","year":"2020","journal-title":"Perspect. Clin. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40264-021-01099-3","article-title":"Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review","volume":"44","author":"Alruqayb","year":"2021","journal-title":"Drug Saf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2215\/CJN.00340118","article-title":"Clinical pharmacokinetics in kidney disease: Fundamental principles","volume":"13","author":"Carland","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e12960","DOI":"10.1111\/ijcp.12960","article-title":"Inappropriate prescribing in chronic kidney disease: A systematic review of prevalence, associated clinical outcomes and impact of interventions","volume":"71","author":"Tesfaye","year":"2017","journal-title":"Int. J. Clin. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100491","DOI":"10.1016\/j.xkme.2022.100491","article-title":"Sick Day Medication Guidance for People With Diabetes, Kidney Disease, or Cardiovascular Disease: A Systematic Scoping Review","volume":"4","author":"Watson","year":"2022","journal-title":"Kidney Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Faber, S.J., Scherpbier, N.D., Peters, H.J.G., and Uijen, A.A. (2019). Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication\u2014An observational study in general practice. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1636-z"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.18773\/austprescr.2017.057","article-title":"Medication management on sick days","volume":"40","author":"Petzel","year":"2017","journal-title":"Aust. Prescr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.ackd.2008.04.009","article-title":"Long-Term Outcomes of Acute Kidney Injury","volume":"15","author":"Goldberg","year":"2008","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/j.ajkd.2008.11.034","article-title":"Long-term Risk of Mortality and Other Adverse Outcomes after Acute Kidney Injury: A Systematic Review and Meta-analysis","volume":"53","author":"Coca","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_17","unstructured":"Kidney Health Australia (2022). How to Sick Day Action Plan, Kidney Health Australia. Available online: https:\/\/kidney.org.au\/uploads\/resources\/KHA-How-To-Sick-Day-Action-Plan-FINAL.pdf."},{"key":"ref_18","unstructured":"Kidneys, T. (2023, October 23). \u201cSick Day\u201d Guidance in Patients at Risk of Acute Kidney Injury: A Position Statement from the Think Kidneys Board. Available online: https:\/\/www.thinkkidneys.nhs.uk\/aki\/wp-content\/uploads\/sites\/2\/2018\/01\/Think-Kidneys-Sick-Day-Guidance-2018.pdf."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s40620-022-01497-5","article-title":"Sick day management in people with chronic kidney disease: A scoping review","volume":"36","author":"Duong","year":"2022","journal-title":"J. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/0002512-200926020-00004","article-title":"Pharmacist-Based Medication Review Reduces Potential Drug-Related Problems in the Elderly","volume":"26","author":"Vinks","year":"2009","journal-title":"Drugs Aging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40266-016-0357-2","article-title":"Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model","volume":"33","author":"Chen","year":"2016","journal-title":"Drugs Aging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2019020","DOI":"10.4178\/epih.e2019020","article-title":"Impact of pharmacist-led home medicines review services on drug-related problems among the elderly population: A systematic review","volume":"41","author":"Gudi","year":"2019","journal-title":"Epidemiol. Health"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Duong, H., Tesfaye, W., Van, C., Sud, K., and Castelino, R.L. (2023). Hospitalisation Due to Community-Acquired Acute Kidney Injury and the Role of Medications: A Retrospective Audit. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093347"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s11255-023-03533-0","article-title":"Clinical characteristics and outcomes of community acquired-acute kidney injury","volume":"55","author":"Tso","year":"2023","journal-title":"Int. Urol. Nephrol."},{"key":"ref_25","unstructured":"WHO (2023). ICD-11 Coding Tool Mortality and Morbidity Statistics (MMS), WHO. Available online: https:\/\/icd.who.int\/ct11\/icd11_mms\/en\/release."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Pharmaceutical Society of Australia (2013). Chapter 1: Definition and classification of CKD. Kidney Int. Suppl., 3, 19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"key":"ref_27","unstructured":"MDCalc (2023). Charlson Comorbidity Index, MD Calc. Available online: https:\/\/www.mdcalc.com\/calc\/3917\/charlson-comorbidity-index-cci."},{"key":"ref_28","unstructured":"(2022). Anatomical Therapeutic Chemical (ATC) Classification System, Norweigan Institute of Public Health. Available online: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11096-011-9583-1","article-title":"Document: A system for classifying drug-related problems in community pharmacy","volume":"34","author":"Williams","year":"2012","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Truong, M., Tesfaye, W., Sud, K., Van, C., Seth, S., Croker, N., and Castelino, R.L. (2024). Drug-Related Problems and Sick Day Management Considerations for Medications that Contribute to the Risk of Acute Kidney Injury. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020343"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2147\/TCRM.S116789","article-title":"Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital","volume":"12","author":"Yang","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104910","DOI":"10.1016\/j.archger.2022.104910","article-title":"Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation","volume":"107","author":"Quek","year":"2023","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajag.12676","article-title":"Process, impact and outcomes of medication review in Australian residential aged care facilities: A systematic review","volume":"38","author":"Chen","year":"2019","journal-title":"Australas. J. Ageing"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.sapharm.2021.04.022","article-title":"Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials","volume":"18","author":"Cheema","year":"2022","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/11316440-000000000-00000","article-title":"Impact of Residential Medication Management Reviews on Drug Burden Index in Aged-Care Homes","volume":"26","author":"Nishtala","year":"2009","journal-title":"Drugs Aging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11096-009-9287-y","article-title":"Drug-related problems identified in medication reviews by Australian pharmacists","volume":"31","author":"Stafford","year":"2009","journal-title":"Pharm. World Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bolmsj\u00f6, B.B., Palagyi, A., Keay, L., Potter, J., and Lindley, R.I. (2016). Factors influencing deprescribing for residents in Advanced Care Facilities: Insights from General Practitioners in Australia and Sweden. BMC Fam. Pract., 17.","DOI":"10.1186\/s12875-016-0551-7"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.clinthera.2020.02.005","article-title":"Drug-related Problems in Home-dwelling Older Adults: A Systematic Review","volume":"42","author":"Herdeiro","year":"2020","journal-title":"Clin. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"i49","DOI":"10.1093\/intqhc\/mzg085","article-title":"Adverse drug events and medication errors in Australia","volume":"15","author":"Runciman","year":"2003","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/11531560-000000000-00000","article-title":"Drug Burden Index and Potentially Inappropriate Medications in Community-Dwelling Older People","volume":"27","author":"Castelino","year":"2010","journal-title":"Drugs Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/24740527.2020.1749516","article-title":"Community pharmacists and chronic pain: A qualitative study of experience, perception, and challenges","volume":"4","author":"Tabeefar","year":"2020","journal-title":"Can. J. Pain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11096-012-9701-8","article-title":"An evaluation of medication review reports across different settings","volume":"35","author":"Freeman","year":"2013","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejim.2014.07.011","article-title":"Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing","volume":"25","author":"Vidal","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.japh.2018.04.026","article-title":"Impact of pharmacist identification of medication-related problems in a nontraditional long-term care pharmacy","volume":"58","author":"Pepe","year":"2018","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaip.2016.03.007","article-title":"Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations","volume":"4","author":"Ryan","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_47","unstructured":"Pharmaceutical Society of Australia (2020). Guidelines for Comprehensive Medication Management Reviews, Pharmaceutical Society of Australia."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40266-014-0208-y","article-title":"Impact of the Pharmacist Medication Review Services on Drug-Related Problems and Potentially Inappropriate Prescribing of Renally Cleared Medications in Residents of Aged Care Facilities","volume":"31","author":"Gheewala","year":"2014","journal-title":"Drugs Aging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1071\/HC19106","article-title":"Avoiding acute kidney injury in primary care: Attitudes and behaviours of general practitioners and community pharmacists in Hawke\u2019s Bay","volume":"12","author":"Vicary","year":"2020","journal-title":"J. Prim. Health Care"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/5\/798\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:44:23Z","timestamp":1760107463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/5\/798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["medicina60050798"],"URL":"https:\/\/doi.org\/10.3390\/medicina60050798","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]}}}